Introduction
The problems of toxicity, uptake, distribution and excretion of methylmercury in humans and experimental animals have been dealt with by many authors and presented in numerous reports (1) (2) (3) (4) (5) monographs (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) , and current communications (16) (17) (18) (19) (20) . However, most reports have concentrated on specific aspects of these problems. Complex studies considering dose-dependent retention, excretion, distribution (organ and subcellular) and binding of methylmercuric chloride to cell components depending on the dose and route of administration of methylmercury are lacking.
Although clinical symptoms of toxicity of methymercuric compounds are well known (2), trials of treatment or amelioration of its toxic effects are still in the experimental stage.
It has been established that interaction of selenium with inorganic mercury results in a decreased uptake of mercury at the site of its administration and decreases its excretion with urine and feces. The concentrations of mercury in the liver and blood are significantly enhanced, but simultaneously the mercury content of the kidney is significantly reduced (21) (22) (23) (24) . These changes are most pronounced when mercury and selenium are administered at at least equimolar doses (21- *Department of Toxicological Chemistry, Institute of Environmental Research and Bioanalysis, Medical Academy of L6dt, Narutowicza 120 A, 90-145 L6d&, Poland. 25 ). The sequence of administration of both these elements is also important. The effect of selenium on the distribution of mercury is smaller when the selenium is administered after mercury than in the case of simultaneous exposure to both these metals (26, 27) .
The protective action of sodium selenite against the nephrotoxic effect of inorganic mercury (13, (28) (29) (30) (31) (32) (33) (34) and the beneficial action of selenium in methylmercury poisoning has been described by many authors (33, (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) . Sodium selenite administration results in delayed occurrence of symptoms of neurological and histological disturbances and in enhanced life expectancy of exposed animals (40, 43, 48) .
Results of studies on the selenium-methylmercury interaction are sometimes contradictory. Selenium has been reported to increase whole-body retention ofmethylmercury (35) , increase levels of methylmercury in brain, liver, blood, and spleen while reducing the mercury content at kidneys. The effect on brain, noted by many investigators (41, (49) (50) (51) , is of special interest, since no symptoms of intoxication were observed in animals receiving sodium selenite simultaneously with methylmercury, even though the concentration of methylmercury in their brain exceeded critical values (13, 15) . In other studies simultaneous administration of selenium was reported to result in significant changes in the distribution of methylmercury in the body (34, 41, 45) . There are also reports stating that if selenium affects the methylmercury concentration in the blood at all, it re-sults in a decrease rather than an increase (52) and that this effect is attributable to a selenium-induced decrease in the affinity of red blood cells for methylmercury (52) .
These discrepancies prompted the present study of the effect of selenium on excretion, whole-body retention, and organ and subcellular distribution and binding of selenium to proteins of the soluble fraction of the liver and kidneys. An effort has been made to relate the results to dose and route of methylmercuric chloride administration in rats.
Materials and Methods
Female Wistar rats, body weight 150-200 g, fed standard LSM diet and allowed to drink tap water ad libitum were used in this study. The animals were divided into eight groups. Data on the group size, compounds administered, routes of administration and doses applied are given in Table 1 .
The animals were exposed to the metals for 2 weeks. The concentrations of mercury in tissues of rats exposed intragastrically (group I) or intraveneously (group II) to the lower dose of methylmercury (0.25 mg Hg/ kg) are shown in Table 3 . For both routes of exposure, the lowest concentration (1-3 ,ug Hg/g tissue) were found in the brain, lungs, heart, liver, intestines, muscles, bones, and skin. Mercury concentrations in the spleen and blood and kidneys were 7 and 10 ,ug Hg/g tissue, respectively.
A tenfold higher dose of methylmercury (2.5 mg Hg/ kg) supplied either intragastrically (group III) or intraveneously (group IV) resulted in a proportional tenfold increase in the concentration of 203Hg in respective tissues (Table 4) .
Sodium selenite supplied at a tenfold excess with respect to mercury given both intragastrically (group Ia) and intraveneously (group Ha) elevated the concentration of 203Hg in the brain about twofold and decreased it in the blood and kidneys (Table 3 ). An equimolar dose of selenium with respect to mercury had the greatest effect on the concentration of 203Hg in the brain of rats, increasing it as in the case of selenium excess (Table 4) .
Due to the similarity of results for both routes of administration of methylmercury, concentrations of 203Hg in organelles of the liver and kidneys expressed per milligram protein are shown jointly in Tables 5 and  6 without indicating the type of exposure.
In animals exposed to the low dose of methylmercury (0.25 mg Hg/kg) the concentrations of 203Hg in subcel- In the soluble fraction ofthe liver, retaining this metal with the highest efficiency irrespective of the routeof administration and dose of methylmercury, 203Hg was bound almost completely by high molecular weight proteins (Fig. 5 ) and the amount of metal bound to proteins depended only on the concentration of "3Hg in the total soluble fraction. Sodium selenite did not affect the binding pattern of mercury to proteins ofthe soluble fraction of the liver.
The excess of selenium practically did not alter the level ofmercury (per mg protein) in subcellular fractions of the liver. The only exception was the soluble fraction in which the concentration of mercury decreased (Table  5 ).
An equimolar dose of selenium induced a considerable dimunition of the level of mercury in the light lysosomal fraction and a simultaneous increase of its level in the remaining fractions. The highest elevation took place in the microsomal fraction (Table 5 ).
In the kidneys of rats exposed to the lower dose of methylmercury (0.25 mg Hg/kg) the concentration of 'Hg referred to the protein content (Table 6 ) was the highest in the microsomal, soluble and membrane fractions.
After application of the tenfold higher dose of meth- ylmercury the highest concentrations of mercury were found in the soluble, light lysosomal and microsomal fractions.
In the kidneys of rats given 2.5 mg Hg/kg the soluble fraction had the highest contribution to the accumulation of 203Hg, as in the case of the lower dose ( Table 6 ).
The excess of selenium with respect to mercury (Groups Ia and Ha) which decreased the concentration of mercury in the kidneys (Tables 3 and 4 (Table 6 ).
The binding of 203Hg by proteins of the subcellular fractions of rat kidneys was dependent only on the dose of methylmercury and the presence of sodium selenite and was independent of the route of administration of methylmercuric chloride. The pattern of binding of 'Hg to proteins of the soluble fraction of the kidneys as a function of the dose of methylmercuric chloride and the presence of selenium is shown in Figure 6 . In rats exposed to the low dose of methylmercuric chloride (0.25 mg Hg/kg, groups I and II) mercury was bound by proteins of the soluble fraction of the kidneys eluted in three distinct peaks (Fig. 6) . High molecular weight proteins bound 35.6 and 40.7% of mercury, depending on the molecular weight; protein of molecular weight of about 10,000 (probably metallothioneinlike proteins) linked about 20 .4% of 03Hg accumulated in this fraction in the kidneys.
In the case of the higher dose (2.5 mg Hg/kg) of methylmercuric chloride (groups III and IV) mercury was bound in the form of two peaks to high molecular weight proteins and to low molecular weight proteins (metallothionein), with 34.3, 44.5, and 18.8% of the total metal contained in this fraction, respectively (Fig. 6) .
Sodium selenite administered at a tenfold excess with respect to mercury (groups Ia and IIa) brought about a considerable decrease in the amount of mercury bound to high molecular weight proteins and practically totally 1.0 displaced mercury from metallothioneinlike proteins (Fig. 6) . High molecular weight proteins of the soluble fraction of kidneys of rats of these groups bound, depending on the molecular weight, about 37.2 and 55.8% of 203Hg retained in the fraction.
Discussion
Results presented in this paper may allow determination of the possibility of forecasting the methylmercury concentration in rat tissues on the basis of determination of its concentration in blood, and the effect of the presence of sodium selenite on such estimations.
In the study, two different routes of administration and two significantly different doses of methylmercury (0.25 and 2.5 mg Hg/kg) were employed. This permitted us to obtain different mercury:selenium ratios at a constant dose of selenium ( Table 1) .
The studies performed indicate that, irrespective of the dose and route of administration, the same percent of the cumulative dose of methylmercury was excreted in urine and feces and probably with expired air (1, 14) . As a result, the percent whole-body retention of methylmercury after repeated exposure dose. Upon termination of the exposure, the ratio of the whole-body content of methylmercury to its content in the blood was also almost independent of the dose and route of administration and close to 5 ( (Table 7) . This observation may allow in the future for an estimation of methylmercury concentration in the tissues on the basis of its concentration in the blood, especially when using similar conditions of exposure for different purposes. Very similar values of these ratios can be derived from data of other authors (19, 57, 58) who also employed repeated exposure and, like us, determined methylmercury concentration in tissues and in blood soon (usually 24 hr) after termination of the exposure (Table 7) . Our calculations show that values of those ratios are similar also after single administration of methylmercury (Table 7) if methylmercury concentrations in blood and tissues in short times after exposure are considered (59) (60) (61) .
The presence of selenium, though increasing the wholebody retention of methylmercury only slightly (Table  2 ) changed its levels in individual tissues significantly, especially in the kidneys and brain, irrespective of the dose and route of administration of the latter (Tables 3  and 4 ). This is reflected by significantly altered numerical values of the tissue: blood methylmercury concentration ratios (Table 8) Table 4 when the molar dose of selenium was lower than the molar dose of methylmercury (expressed as metalic mercury). This effect was observed for both single (50, 51) and repeated administration of methylmercury. However the mechanism involved remains unknown. On the other hand, selenium affects the level of methylmercury in rat kidneys significantly, and in this case a clearcut diminution of the methylmercury concentration is attained only when selenium excess with respect to mercury is employed (Table 3 ). This effect is observed in all subcellular fractions of this organ; in the soluble fraction, the decrease includes the amount of methylmercury bound to both high molecular weight and low molecular weight protein fractions (Fig. 6) . As a result, the kidneys:blood methylmercury concentration ratio is decreased, especially for selenium excess (Table 8 ).
Numerous studies indicate that the interaction effect of selenium and inorganic mercury is different and is characterized by a clear-cut translocation of mercury from low molecular to high molecular weight kidney proteins (24, 26, 27, 64) already at equimolar concentrations of mercury and selenium (27) . This phenomenon is accompanied by about a fivefold diminution of mercury concentration in the kidneys and inhibition of metallothionein biosynthesis (26, 27, (64) (65) (66) . Simultaneously a distinct, about fourfold increase of the level of this metal is observed, especially in the mitochondrial and nuclear fractions (26) and concentration of mercury in the blood increases considerably (25, 27, 67) . Such effects are not observed in methylmercury-selenium interaction. In this case no increase but rather a decrease in the methylmercury concentration is found in the blood, regardless of whether selenium was administered at an equimolar dose (Table 4 ) or in slight (65) or considerable (Table 3) excess. Usually it is accompanied by only a small increase of the methylmercury concentration in the liver (Tables 3 and 4) (65) . The binding pattern of Me203Hg to proteins of the soluble fraction ofthe kidneys (Fig. 6) points to a possible participation of metallothionein-like proteins in this process (15, 68) . That is probably due to the higher efficiency of biotransformation of methylmercury to inorganic mercury in rat kidneys as compared with liver (58, 65, 69, 70) ; this process seems to be strictly dependent on the dose of methylmercury which has been taken into account in our further studies (71) .
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